A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin exposure

By sjmartinez • November 15, 2024

Leong M, Dai T, Tong L, Nast CC. A case of karyomegalic interstitial nephritis without FAN1 mutations in the setting of brentuximab, ifosfamide, and carboplatin exposure. BMC Nephrol. 2024 Nov 14;25(1):409. doi: 10.1186/s12882-024-03689-6. PMID: 39543462.

Tags: Brentuximab, FAN1, Karyomegalic interstitial nephritis, Nephrology, Publications

Obesity and Cardio-Metabolic Health in Kidney Disease: Implications for Kidney Health, Risk Stratification, and Management

Mathew RO, Hong A, Narasaki Y, Fung E, Cheung D, Han J, Durstenfeld MS, Hsue PY, Rhee CM. Obesity and Cardio-Metabolic Health in Kidney Disease:[...]

Enhancing Evidence Generation by Linking Randomized Clinical Trials to Real-World Data: The INVESTED-Medicare Linkage Study

Cho H, Shin H, Najafzadeh M, Claggett B, Ortega-Montiel J, Liu J, Paik JM, Lalani NF, Bradley MC, Concato J, Solomon SD, Vardeny O, Patorno[...]

Comparative Short-term Risk of Severe Gastrointestinal Events Associated With Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

Bea S, Patorno E, Sreedhara SK, Wexler DJ, Cromer SJ, Glynn RJ, Paik JM, Bykov K. Comparative Short-term Risk of Severe Gastrointestinal Events Associated With[...]